These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16611154)

  • 21. Emerging targets in migraine.
    Hoffmann J; Goadsby PJ
    CNS Drugs; 2014 Jan; 28(1):11-7. PubMed ID: 24318669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan.
    Goadsby PJ; Hargreaves RJ
    Neurology; 2000; 55(9 Suppl 2):S8-14. PubMed ID: 11089513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of action of the 5-HT1B/1D receptor agonists.
    Tepper SJ; Rapoport AM; Sheftell FD
    Arch Neurol; 2002 Jul; 59(7):1084-8. PubMed ID: 12117355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Present and future of 5-HT receptor agonists as antimigraine drugs.
    Pauwels PJ; John GW
    Clin Neuropharmacol; 1999; 22(3):123-36. PubMed ID: 10367177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basic mechanisms of migraine and its acute treatment.
    Edvinsson L; Villalón CM; MaassenVanDenBrink A
    Pharmacol Ther; 2012 Dec; 136(3):319-33. PubMed ID: 22939884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
    Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Putative role of 5-HT
    Segelcke D; Messlinger K
    Cephalalgia; 2017 Apr; 37(4):365-371. PubMed ID: 27127104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of migraine--new insights.
    Hargreaves RJ; Shepheard SL
    Can J Neurol Sci; 1999 Nov; 26 Suppl 3():S12-9. PubMed ID: 10563228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety of triptans in the treatment of patients with migraine.
    Jamieson DG
    Am J Med; 2002 Feb; 112(2):135-40. PubMed ID: 11835952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of migraine and action of antimigraine medications.
    Spierings EL
    Med Clin North Am; 2001 Jul; 85(4):943-58, vi-vii. PubMed ID: 11480266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathophysiology of migraine: year 2005.
    Buzzi MG; Moskowitz MA
    J Headache Pain; 2005 Jun; 6(3):105-11. PubMed ID: 16355290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance P receptor antagonists in the therapy of migraine.
    May A; Goadsby PJ
    Expert Opin Investig Drugs; 2001 Apr; 10(4):673-8. PubMed ID: 11281817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can we develop neurally acting drugs for the treatment of migraine?
    Goadsby PJ
    Nat Rev Drug Discov; 2005 Sep; 4(9):741-50. PubMed ID: 16121129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into the molecular actions of serotonergic antimigraine drugs.
    Durham PL; Russo AF
    Pharmacol Ther; 2002; 94(1-2):77-92. PubMed ID: 12191595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Hydroxytryptamine and the pathophysiology of migraine.
    Humphrey PP
    J Neurol; 1991; 238 Suppl 1():S38-44. PubMed ID: 2045830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of migraine].
    Hoffmann J; Reuter U
    Dtsch Med Wochenschr; 2007 Oct; 132(41):2153-8. PubMed ID: 17924297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacology of current anti-migraine drugs.
    Peroutka SJ
    Headache; 1990 Jan; 30(1 Suppl):5-11; discussion 24-8. PubMed ID: 1969855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-HT3 receptor antagonists and migraine therapy.
    Ferrari MD
    J Neurol; 1991; 238 Suppl 1():S53-6. PubMed ID: 2045832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Physiopathology of migraine].
    Goadsby PJ; Lance JW
    Rev Prat; 1990 Feb; 40(5):389-93. PubMed ID: 1968676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.